Acasti Pharma Inc. (CVE:ACST – Get Free Report) shares were up 1.8% during mid-day trading on Tuesday. The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Price Performance
The stock’s fifty day moving average price is C$0.58 and its 200 day moving average price is C$0.58. The stock has a market capitalization of C$18.19 million, a P/E ratio of -1.21 and a beta of 1.22.
About Acasti Pharma
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Further Reading
- Five stocks we like better than Acasti Pharma
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
